MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76 | +171.4% | 1,752 | +129.9% | 0.02% | +144.4% |
| Q2 2023 | $28 | -3.4% | 762 | -3.1% | 0.01% | -10.0% |
| Q1 2023 | $29 | +7.4% | 786 | +34.4% | 0.01% | -9.1% |
| Q4 2022 | $27 | -99.9% | 585 | +12.3% | 0.01% | -26.7% |
| Q3 2022 | $36,000 | +80.0% | 521 | +110.9% | 0.02% | +114.3% |
| Q1 2022 | $20,000 | -99.2% | 247 | -98.5% | 0.01% | -98.8% |
| Q4 2021 | $2,362,000 | – | 16,100 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |